Editor’s Note August 23, 2011

OneMedRadio continues to bring you candid interviews with CEOs of some of the most interesting and innovative micro-cap healthcare and life science companies from around the globe.  These companies, often undervalued, have promising futures ahead with many of them appearing at the 5th Annual OneMedForum,  January 9-12th in San Francisco. Mark your calendar.

In this issue:

ThermoGenesis [NASDAQ:KOOL] CEO, Mel Engle, describes the explosive opportunities in Asia and other developments in the regenerative medicine field.

AdvaMed Chief Administrative Officer, Ken Mendez, describes what is planned for the 4th rendition of the MedTech conference.

International Stem Cell Corporation [OTC: ISCO] CEO, Ken Aldrich, is interviewed about this  innovative stem company and the surprisingly rapid rowth of its skin care division. The company released record quarterly revenues August 22nd.

Also, Vasomedical [OTC: VASO.PK] announces agreement to acquire two China-based companies and Entellus completes a $35 million financing.

The comments are closed.